Resumen
Definición
Anamnesis y examen
Principales factores de diagnóstico
- history of psychiatric comorbidity
- positive family history of social anxiety
- anticipatory anxiety and worry
- tachycardia
- hyperventilation
- sweating
- flushing
- muscle tension
Otros factores de diagnóstico
- post-event processing
- attentional biases
- social skills deficits
- crying, tantrums, or "freezing"
- selective mutism
Factores de riesgo
- psychiatric comorbidity (e.g., anxiety, mood, and substance-use disorders)
- genetic
- temperamental factors
- parenting style
- psychological disorder
- life stressors
- environmental factors
Pruebas diagnósticas
Primeras pruebas diagnósticas para solicitar
- clinical diagnosis
Pruebas diagnósticas que deben considerarse
- blood glucose
- serum thyroid-stimulating hormone
- toxicology screen (urine and blood)
Algoritmo de tratamiento
adults: no comorbidity
adults: comorbidities
children and adolescents
Colaboradores
Autores
Craig N. Sawchuk, PhD
Professor
Department of Psychiatry and Psychology
Mayo Clinic
Rochester
MN
Divulgaciones
CNS declares that he has no competing interests.
Jason P. Veitengruber, MD
Associate Professor
Department of Psychiatry and Behavioral Sciences
University of Washington School of Medicine
Seattle
WA
Divulgaciones
JPV is an author of a reference cited in this topic.
Bunmi O. Olatunji, PhD
Professor
Department of Psychological Sciences
Vanderbilt University
Nashville
TN
Divulgaciones
BOO declares that he has no competing interests.
Stacy Shaw Welch, PhD
Director
Anxiety and Stress Reduction Center of Seattle
University of Washington
Seattle
WA
Divulgaciones
SSW declares that she has no competing interests.
Revisores por pares
Stefan G. Hofmann, PhD
Alexander von Humboldt Professor
Department of Psychology
Philipps University Marburg
Germany
Divulgaciones
SGH is an author of a number of references cited in this topic.
Fallon R. Goodman, PhD
Assistant Professor of Psychology
George Washington University
Washington
DC
Divulgaciones
FRG declares that she has no competing interests.
Richard P. Swinson, MD, FRCPC, FRCPsych
Emeritus Professor
Medical Director
Anxiety Treatment and Research Centre
McMaster University and St Joseph’s Hospital
Hamilton
Canada
Divulgaciones
RPS declares that he has no competing interests.
David Baldwin, MD
Professor of Psychiatry
University of Southampton
Southampton
UK
Divulgaciones
DB has acted as a consultant for and held research grants from Cephalon, Eli Lilly, GSK, Lundbeck, Organon, Pfizer, Pharmacia, Roche, and Wyeth and has also acted as a consultant to Asahi, AstraZeneca, Grunenthal, Pierre Fabre, Servier, Sumitomo, and Wyeth. He has accepted paid speaking engagements in industry-supported satellite symposia and is co-author of the BAP evidence-based guidelines on the treatment of anxiety disorders. He is also a Medical Patron of Anxiety UK.
Diferenciales
- Phobias
- Panic disorder
- Agoraphobia
Más DiferencialesGuías de práctica clínica
- Anxiety and depression in children and youth: diagnosis and treatment
- WFSBP guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders- version 3. part I: anxiety disorders
Más Guías de práctica clínicaFolletos para el paciente
Anxiety
Panic attacks
Más Folletos para el paciente
Inicie sesión o suscríbase para acceder a todo el BMJ Best Practice
El uso de este contenido está sujeto a nuestra cláusula de exención de responsabilidad